Related Experiment Video
Updated: Apr 12, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Histone demethylase RBP2 promotes malignant progression of gastric cancer through
Xiuming Liang1, Jiping Zeng2, Lixiang Wang3
1Department of Microbiology/Key Laboratory for Experimental Teratology of Chinese Ministry of Education, School of Medicine, Shandong University, Jinan, PR China.
Abstract:
Some feedback pathways are critical in the process of tumor development or malignant progression. However the mechanisms through which these pathways are epigenetically regulated have not been fully elucidated. Here, we demonstrated that the histone demethylase RBP2 was crucial for TGF-β1-(p-Smad3)-RBP2-E-cadherin-Smad3 feedback circuit that was implicated in malignant progression of tumors and its knockdown significantly inhibited gastric cancer (GC) metastasis both in vitro and in vivo. Mechanistically, RBP2 can directly bind to E-cadherin promoter and suppress its expression, facilitating EMT and distant metastasis of GC. RBP2 can also be induced by TGF-β1, a key inducer of EMT, through phosphorylated Smad3 (p-Smad3) pathway in GC. The upregulated RBP2 can be recruited by p-smad3 to E-cadherin promoter and enhance its suppression, contributing to the promotion of metastasis of GC. In addition, the suppression of E-cadherin by RBP2 attenuated inhibition of Smad3 phosphorylation (exerted by E-cadherin), resulting further induction of RBP2 expression, and thus constituting positive feedback regulation during GC malignant progression. This TGF-β1-(p-Smad3)-RBP2-E-cadherin-Smad3 feedback circuit may be a novel mechanism for GC malignant progression and suppression of RBP2 expression may serve as a new strategy for the prevention of tumor distant metastasis.
Insights
The histone demethylase RBP2 drives gastric cancer (GC) metastasis by suppressing E-cadherin. Targeting RBP2 may inhibit tumor progression and prevent metastasis.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Feedback pathways are crucial in tumor development and malignant progression.
- Epigenetic regulation mechanisms in these pathways remain unclear.
Purpose of the Study:
- To elucidate the role of the histone demethylase RBP2 in gastric cancer (GC) metastasis.
- To investigate the TGF-β1-(p-Smad3)-RBP2-E-cadherin-Smad3 feedback circuit in GC progression.
Main Methods:
- In vitro and in vivo studies involving RBP2 knockdown in GC cells.
- Analysis of RBP2 binding to the E-cadherin promoter.
- Investigation of TGF-β1 and p-Smad3 pathway involvement.
Main Results:
- RBP2 knockdown significantly inhibited GC cell metastasis.
- RBP2 directly suppresses E-cadherin expression by binding to its promoter, facilitating epithelial-mesenchymal transition (EMT) and metastasis.
- TGF-β1 induces RBP2 via the p-Smad3 pathway, creating a positive feedback loop that enhances GC metastasis.
Conclusions:
- A novel TGF-β1-(p-Smad3)-RBP2-E-cadherin-Smad3 feedback circuit promotes GC malignant progression and metastasis.
- RBP2 suppression represents a potential therapeutic strategy to prevent tumor distant metastasis.
Related Concept Videos
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The Ras Gene
Ras is a...
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

